|
 |
ZemplarThis page contains recent news articles, when available, and an overview of Zemplar but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Both Nephrologists and RDs give Zemplar higher performance scores than Hectorol on almost every attribute. About BioTrends Research Group, Inc. BioTrends ... Reuters Abbott gets FDA OK on Zemplar - May 28, 2005 The Food and Drug Administration on Friday approved Abbott Laboratories' Zemplar, an oral vitamin D therapy for kidney patients, and the North Chicago-based ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott Announces FDA Approval of Zemplar(R) (Paricalcitol) Capsules... - May 27, 2005 ABBOTT PARK, Ill., May 27 /PRNewswire-FirstCall/ -- Abbott announced today that the US Food and Drug Administration (FDA) has approved Zemplar(R) ... RedOrbit DaVita gets subpoena tied to federal probe - Dec 15, 2008 O) big-selling anemia drug Epogen, as well as to the drugs Zemplar, Hectorol, Venofer and Ferrlicit. The subpoena seeks documents dating back to January ... Reuters Drug Criteria & Outcomes Paricalcitol (Zemplar) Formulary Evaluation - Feb 1, 2006 Strengths/dosage forms available: Paricalcitol is available in 1 mL and 2 mL single-dose vials (5 mcg/mL) of aqueous solution for intravenous (IV) injection ... Free with registration - Drug Formulary Review - AccessMyLibrary.com … Treatment of Kidney Disease Complication, Zemplar(reg) Shows... - May 4, 2005 Abbott today presented the results of its pivotal Phase III clinical studies for Zemplar(reg) (paricalcitol) Capsules in patients with stage three and four ... Medical News Today - Medical News Today (press release) … , Limited And The Medicine ZEMPLAR.(Patented Medicine Prices R - Aug 21, 2007 ZEMPLAR is indicated for the prevention and treatment of secondary hyperparathyroidism ... The PMPRB's Human Drug Advisory Panel recommended that ZEMPLAR be ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com Abbott Launches ZEMPLAR Capsules (paricalcitol) In The UK For … - Apr 4, 2008 Abbott UK announced the launch of an oral formulation of Zemplar (paricalcitol) for the treatment and prevention of secondary hyperparathyroidism (SHPT), ... Medical News Today - Medical News Today (press release) … Release: Abbott Presents Promising Zemplar(R) (Paricalcitol)... - May 3, 2005 Abbott Presents Promising Zemplar(R) (Paricalcitol) Capsules Phase III Data Showing Potential for Earlier Treatment of Kidney Disease Complication. from PR ... Pay-Per-View - PR Newswire - HighBeam Research … : Abbott Announces FDA Approval of Zemplar(R) (paricalcitol)... - May 27, 2005 Abbott Announces FDA Approval of Zemplar(R) (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … III studies of Abbott's (Abbott Park, IL) Zemplar (paricalcitol)... - Jun 1, 2005 Three Phase III studies of Abbott's (Abbott Park, IL) Zemplar (paricalcitol) in capsules for chronic kidney disease showed good results. Free with registration - Applied Clinical Trials - AccessMyLibrary.com OSNews > Thread > "RE: Idea" by zemplar - Jan 26, 2005 ..."On January 26th, 2005, the Itanium Solutions Alliance (Intel, Hewlett-Packard, SGI, NEC, Hitachi, Bull SA, Fujitsu, and Unisys) proudly announced that its ... OS News New indication for Zemplar.(PRODUCTS)(Brief Article) | Article from … - Oct 1, 2005 New indication for Zemplar.(PRODUCTS)(Brief Article) ... find Internal Medicine News articles. Zemplar (paricalcitol capsules) has been approved for the ... Pay-Per-View - Internal Medicine News - HighBeam Research Empresas.- Abott lanza 'Zemplar' en cápsulas para el tratamiento y … - Sep 29, 2008 Abbott han lanzado paricalcitol en cápsulas, comercializado por la empresa como 'Zemplar', para la prevención y el tratamiento del hiperparatiroidismo ... ecodiario Empresas.- SEN dice que 'Zemplar' (Abbott) es "una innovación … - Oct 9, 2008 La nueva versión en cápsulas de 'Zemplar' (paricalcitol), de laboratorios Abbott, supone "una innovación importante" para el control del metabolismo ... ecodiario Article: Students protest drug industry over U. Wisconsin-developed... - Apr 23, 2007 Students protested Abbott Laboratories withdrawal of Zemplar, ... Zemplar was created by UW-Madison Steenbock research professor Dr. Hector DeLuca. ... Pay-Per-View - University Wire - HighBeam Research BioTrends Releases Two Publications - TreatmentTrends(TM): … - May 6, 2008 Zemplar continues to dominate in dialysis with 72% market share and Nephrologists project Zemplar to take the market leader position in CKD from Calcitriol ... RedOrbit RE[3]: Damn, can't download it! - Feb 18, 2006 I also have to agree with zemplar, it is your loss. I also have to agree with zemplar, it is your loss. ... My question to zemplar was What kind of loss? ... OS News IV versus PO Vitamin D: the road already traveled.(Controversies in … - May 1, 2006 Of note is that oral paricalcitol (Zemplar[TM]) does not carry an indication for patients with CKD Stage 5. Although the price for injectable vitamin D is ... Free with registration - Nephrology Nursing Journal - AccessMyLibrary.com Press Release: BioTrends Releases Two Publications - TreatmentTrends(... - May 6, 2008 Zemplar continues to dominate in dialysis with 72% market share and Nephrologists project Zemplar to take the market leader position in CKD from Calcitriol ... Pay-Per-View - PR Newswire - HighBeam Research Research universities must act - Oct 3, 2007 Critically, among the seven drugs that Abbott withdrew is Zemplar, a life-saving kidney medication developed by scientists at the University of Wisconsin. ... Boston Globe IV versus PO Vitamin D: the road already traveled.(Controversies in … - May 1, 2006 Of note is that oral paricalcitol (Zemplar[TM]) does not carry an indication for patients with CKD Stage 5. Although the price for injectable vitamin D is ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Research universities must act - Nov 10, 2007 Critically, among the seven drugs that Abbott withdrew is Zemplar, ... The University of Wisconsin must demand that Abbott reinstates Zemplar on the Thai ... ประชาไท BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report … - Jul 25, 2008 In the treatment of secondary hyperparathyroidism, Abbott's Zemplar continues to ... Zemplar and Hectorol receive significantly higher ratings than Amgen's ... Genetic Engineering News - Genetic Engineering News (press release) ESA use in CKD patients decreases due to managed care policies, … - Jul 28, 2008 In the treatment of secondary hyperparathyroidism, Abbott's Zemplar continues to ... Zemplar and Hectorol receive significantly higher ratings than Amgen's ... Renal Business Today Press Release: Cytochroma reports positive Phase I clinical data for ... - Jun 28, 2007 Article: Zemplar(R) (Paricalcitol Injection): The Most Widely Used Therapy ... ... In the treatment of secondary hyperparathyroidism, Abbott's Zemplar ... Pay-Per-View - PR Newswire - HighBeam Research Motorola wins a ratings boost - Jun 5, 2005 Combined with its injectable version of Zemplar already on the market, sales could reach $1 billion, the North Chicago-based company said. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Press Release: Cytochroma appoints co-founder Dr. P. Martin Petkovich... - Mar 12, 2007 Article: Zemplar(R) (Paricalcitol Injection): The Most Widely Used Therapy ... ... In the treatment of secondary hyperparathyroidism, Abbott's Zemplar ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: BioTrends Releases Quarterly TreatmentTrends(TM): … - Jul 25, 2008 In the treatment of secondary hyperparathyroidism, Abbott's Zemplar continues to ... Zemplar and Hectorol receive significantly higher ratings than Amgen's ... Pay-Per-View - PR Newswire - HighBeam Research Joel Z. Melnick, MD joins Cytochroma as Vice President, Clinical &... - Aug 13, 2007 ..."Cytochroma now counts among the senior management team the key individuals responsible for developing and commercializing Hectorol(R) and Zemplar(R), ... Free with registration - PR Newswire - AccessMyLibrary.com Genzyme Reports Strong Third-Quarter Financial Results. - Oct 12, 2006 It showed equally lower mortality rates among patients treated for secondary hyperparathyroidism with Vitamin D2 analogs Hectorol and Zemplar(R) ... $4.95 - PR Newswire - ECNext New indication for avandia.(PRODUCTS)(Brief Article) | Article from … - May 1, 2005 Article: New indication for Zemplar.(PRODUCTS)(Brief ... ... Zemplar (paricalcitol capsules) has been approved for the treatment of secondary ... Pay-Per-View - Internal Medicine News - HighBeam Research Press Release: Joel Z. Melnick, MD joins Cytochroma as Vice President,... - Aug 13, 2007 ..."Cytochroma now counts among the senior management team the key individuals responsible for developing and commercializing Hectorol(R) and Zemplar(R), ... Pay-Per-View - PR Newswire - HighBeam Research WARF SHOULD STAND AGAINST DRUG BOYCOTT.(OPINION)(GUEST … - Oct 31, 2007 One of these seven medications was Zemplar, a vitamin D product developed at UW by Dr. Hector DeLuca. It is used in the treatment of chronic kidney disease. ... Pay-Per-View - Wisconsin State Journal - HighBeam Research … ; Roche gets OK for HIV drug; FDA approves Zemplar; and much more... - May 26, 2005 The FDA has approved Abbott's Zemplar (paricalcitol) for the prevention and treatment of secondary hyperparathyroidism. Release ... FierceBiotech Press Release: New Study by BioTrends Highlights Practice Management … - Jun 5, 2008 Abbott's active vitamin D agent, Zemplar, also enjoyed positive gains and 24% of EU Nephrologists agree that Zemplar offers improved morbidity and mortality ... Pay-Per-View - PR Newswire Europe - HighBeam Research Nephrologists Report Practice Pattern Shifts in the Management of … - Jan 31, 2007 In the CKD setting, nephrologists report a growing preference for Abbott's Zemplar capsules, although more than half view the oral forms of Hectorol and ... $4.95 - PR Newswire - ECNext Press Release: Nephrologists Report Practice Pattern Shifts in the … - Jan 31, 2007 In the CKD setting, nephrologists report a growing preference for Abbott's Zemplar capsules, although more than half view the oral forms of Hectorol and ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Study by BioTrends Highlights Practice Management … - Jun 5, 2008 Abbott's active vitamin D agent, Zemplar, also enjoyed positive gains and 24% of EU Nephrologists agree that Zemplar offers improved morbidity and mortality ... Pay-Per-View - PR Newswire - HighBeam Research Factiva Search - Jun 8, 2005 Abbott's Zemplar Capsules Approved for Earlier Treatment of SHPT ... The FDA has approved Abbott Laboratories' Zemplar capsules, an oral, activated vitamin ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Renal Care Group Inc acquires Cape County Regional Dialysis - Deal … - Jan 5, 2005 Labs: clinical publications projects; Abbott Renal Care: Zemplar; Elan Pharmaceuticals: Zonegran; Merck…laser eye surgery; Hartford Medical Group: hospital ... Pay-Per-View - deals - Alacra Store paricalcitol Abbott marketed, UK (hyperparathyroidism).(Brief Article) - Jun 13, 2005 ...paricalcitol, 49510, ZEMPLAR, M5X, Other Musculoskeletal Products, H3B, Antithyroid Preparations, Abbott, marketed, UK. Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Press Release: SHIRE PLC - IFRS results for the year ending December ... - Mar 23, 2007 Abbott's US renal care sales team will co-promote FOSRENOL with its own renal product ZEMPLAR. Shire's US sales force will also continue to promote FOSRENOL ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Une nouvelle étude menée par BioTrends met en lumière des … - Jun 6, 2008 L'agent actif de vitamine D d'Abbott, Zemplar, a lui aussi connu de bons résultats. En effet, 24 % des néphrologues dans l'UE ont reconnu que Zemplar ... Caducée.net Accueil / Actualités / Economie / 0708132325 : Joel Z. Melnick, MD... - Aug 13, 2007 ...les approbations de commercialisation ainsi que le soutien après le lancement des capsules et de l'injection du Zemplar(R) (paricalcitol), ... Intelink Movers: Apple, Davita, Huntsman - Dec 15, 2008 In response to subpoena, DVA will produce a wide range of documents relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlicit, ... BusinessWeek El doctor Joel Z. Melnick se une a Cytochroma como vicepresidente de ... - Aug 13, 2007 ..."Cytochroma, en su equipo directivo, cuenta ahora con personas clave responsables de desarrollar y comercializar Hectorol(R) y Zemplar(R), dos productos que ... ITNews OSNews > Thread > "cool but..." by Zedicus - Feb 23, 2006 ...by zemplar on Thu 23rd Feb 2006 19:57 in reply to "cool but..." Indeed, there are many advantages of Solaris over GNU/Linux, but most are server oriented ... OS News Cambridge biotech firm to acquire Bone Care. - May 5, 2005 Hectorol is the second-highest-selling vitamin D substitute after Abbott Laboratories' Zemplar. In a note to brokerage clients, JPMorgan analyst Ronald ... Free with registration - Boston Globe - AccessMyLibrary.com OSNews > Thread > "Uh." by ormandj - Feb 10, 2006 ...by zemplar on Fri 10th Feb 2006 23:44 in reply to "Uh." I'm also a Solaris/FreeBSD guy and don't understand the economics of it either. ... OS News Contract manufacturing organizations expand in high-potency … - Sep 1, 2006 SAFC manufactures paricalcitol, the active ingredient in Abbott Laboratories' (Abbott Park, IL. www. abbott.com) "Zemplar," a synthetically manufactured ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com Drug industry's ills may slow its growth ; Criticism is fevered after... - Jan 5, 2005 PHOTO Laura Williams, director of renal research and development for Abbott Laboratories, displays the old, intravenous version of its Zemplar kidney ... Pay-Per-View - Chicago Tribune - ProQuest Archiver HEART DISEASE In middle-aged ... | Article from The Washington Post |... - Mar 15, 2005 About 73 percent got vitamin D injections (mostly Calcijex or Zemplar). Injections were given for varying lengths of time; the average number of doses was ... Pay-Per-View - Washington Post - HighBeam Research Recent Actions by the Food and Drug Administration - Mar 28, 2005 The safety and efficacy of paricalcitol (Zemplar ® ; Abbott) was studied in a 12-week trial in 29 children with end-stage renal disease. ... Medscape Cellectar, state in new territory; Wisconsin sprouting companies at... - May 4, 2008 DeLuca says his lab has produced eight pharmaceuticals, including Zemplar for Abbott Labs, that are marketed around the world. DeLuca and his wife, ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research United States top 200 brand and generic drugs used in hospitals in … - Jun 19, 2006 409547209.35 41.92 43 Aricept 407429788.53 18.46 44 Avonex 401154652.75 29.57 45 Protonix IV 395522352.00 21.30 46 Zemplar 394511777.11 14.81 47 Toprol ... $20.00 - Drug Topics - Alacra Store Cellectar, state in new territory - Wisconsin sprouting companies at ... - May 4, 2008 DeLuca says his lab has produced eight pharmaceuticals, including Zemplar for Abbott Labs, that are marketed around the world. DeLuca and his wife, ... $2.95 - Milwaukee Journal Sentinel - NewsBank Article: Agency A-to-Z: the indispensable guide to healthcare... - Jul 1, 2006 Healthcare accounts: Abbott Labs: Zemplar international; Alexion Pharmaceuticals: Soliris; Amgen Inc.: Aranesp, Kepivance, Neulasta; Amgen ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Deltanoid gets $12 million in financing - WARF director will join... - Dec 18, 2007 Work done in DeLuca's lab has led to the development of 10 drugs, including Zemplar, which has the majority of the market for preventing and treating ... $2.95 - Milwaukee Journal Sentinel - NewsBank Analysis: Abbott pulls drugs from Thailand. - Mar 14, 2007 In addition, Abbott will also not make available Humira for rheumatoid arthritis, Zemplar for kidney disease, Clivarine to prevent blood clots, ... Free with registration - UPI Health Business - AccessMyLibrary.com Cytochroma y Mitsubishi Tanabe crean una asociación para las terapias... - Jul 30, 2008 ...incluyendo Zemplar(R) y Hectorol(R), actualmente las dos principales terapias hormonales con Vitamina D empleadas en el tratamiento de SHPT en EE.UU. ... Finanzas.com เครืà¸à¸‚่ายผู้ติดเชื้à¸à¸¯-ผู้บริโภค รณรงค์ " - Mar 14, 2007 ...ที่ผ่านมา เพื่à¸à¹€à¸žà¸´à¸?ถà¸à¸™à¸„ำขà¸à¸‚ึ้นทะเบียนยา ใหม่ในประเทศไทย 4 ตำรับ ได้à¹?à¸?่ Zemplar ... ประชาไท Thai health groups urge boycott of US drug maker for blocking new … - Mar 20, 2007 ...the blood-clotting medicine Clivarine, arthritis drug Humira, high-blood pressure medication Tarka, and kidney disease drug Zemplar. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Specialty pharmaceutical company reports sharply higher sales. - Apr 27, 2005 ...and he expects Hectoral will continue to perform well, though Abbott Laboratories is due to launch an oral version of Zemplar, its Hectoral competitor, ... Free with registration - Wisconsin State Journal - AccessMyLibrary.com American Kidney Fund launches Part D grant program - Apr 3, 2007 The program covers bone disease medications, including Fosrenol, Hecterol, Phoslo, Renagel, Sensipar and Zemplar. Burton added that the AKF hopes to add ... Renal Business Today Calcitriol - promising chemopreventive agent that may prevent... - Nov 3, 2005 QW, developed at Johns Hopkins University and paricalcitol (Zemplar) have been shown to reduce parathyroid hormone levels (which regulate the metabolism of ... News-Medical.net Research Advances New Cancer Preventive Strategies from Myriad … - Nov 7, 2005 QW, developed at Johns Hopkins University, and paricalcitol (Zemplar) have been shown to reduce the levels of the hormones which regulate the metabolism of ... Medical News Today - Medical News Today (press release) ABBOTT REVIEWS 2004 ACCOMPLISHMENTS AT ANNUAL … - Apr 23, 2005 In 2004, Abbott submitted seven regulatory applications to the FDA for new medications/indications, including Zemplar® ( paricalcitol ) Capsules, ... i-newswire.com Cytochroma Announces Positive Comparative Data On CTA018 In … - Nov 7, 2008 ...paricalcitol (Zemplar(R)), the latter currently being the most widely used therapy for secondary hyperparathyroidism (SHPT) in the United States (US). ... Medical News Today - Medical News Today (press release) American Kidney Fund Unveils Results From First Large-Scale Survey On... - Jul 20, 2007 This program covers commonly prescribed bone disease medications, including Fosrenol®, Hectorol®, Phoslo®, Renagel®, Sensipar® and Zemplar®. ... Medical News Today - Medical News Today (press release) Moderate Renal Dysfunction Linked to Hip Fracture in Older Women - Jan 22, 2007 Several active vitamin D compounds, such as calcitriol and Zemplar (paricalcitol), as well as the prohormones alfacalcidol and Hecterol (doxercalciferol) ... MedPage Today Draftfcb Healthcare: continued upswing from organic growth and a... - Jul 1, 2007 However, Draftfcb lost the account for Opana's Endo, as well as Abbott's diabetes care line and its weight drug Meridia and Zemplar IV/oral, ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com OSNews is Exploring the Future of Computing - Jul 8, 2005 I also have to agree with zemplar, it is your loss. Reader comments are owned by the poster. We are not responsible for them in any way. ... OS News Vitamin D Compounds Show Promise for Prevention of Prostate Cancer - Oct 26, 2005 QW, developed at John's Hopkins University, and paricalcitol (Zemplar?) are less calcemic vitamin D analogs. QW and paricalcitol have been shown to reduce ... newswise.com VITAMIN D AND RELATED COMPOUNDS (Oral route, Parenteral route).( … - May 1, 2007 Zemplar Brand names in the Canada -- * D-Vi-Sol * Radiostol Forte Dosage forms -- * Capsule * Tablet * Liquid * Capsule, Liquid Filled * Solution ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Abbott Laboratories at Morgan Stanley Healthcare Conference - Final. - May 4, 2005 We have Zemplar Capsules, soon to be approved. As you know that was filed last August. We filed Xinlay at the end of last year. We filed two indications for ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com BUSINESS BRIEFS.(TO THE POINT) - May 31, 2005 Abbott Labs won FDA approval for its Zemplar capsules to prevent and treat a complications associated with kidney disease. Shares fell 0.5% to 48. Free with registration - Investor's Business Daily - AccessMyLibrary.com R.Ph.s vital to dialysis teams.(LETTERS)(Letter to the Editor) - Aug 22, 2005 Using dosing protocols, I monitor labs and write orders for Epogen (epoetin alfa, Amgen), intravenous iron, and Zemplar (paricalcitol, Abbott). ... Free with registration - Drug Topics - AccessMyLibrary.com Booming chemical company plans expansion to Verona - Aug 5, 2008 The first major client for Tetrionics was Abbott Laboratories, which still hires SAFC to make the vitamin D compound that goes into Zemplar, ... Verona Press Managing ESRD following MI.(Clinical Twisters)(end-stage renal... - Jun 20, 2005 If calcium control continues to be a problem, calcitriol could be changed to another vitamin D analog such as paricalcitol (Zemplar, Abbott) or ... Free with registration - Drug Topics - AccessMyLibrary.com OSNews > Thread > "RE: ..." by andrewg - Jul 6, 2005 However, you shouldn' be fooled into thinking that your opinion is the be-all and end-all of "what matters in Solaris." by zemplar on Mon 18th Dec 2006 ... OS News How to take Calcitriol from Consumer Reports Health. - Jan 4, 2005 DHT), doxercalciferol (Hectorol), ergocalciferol (Drisdol, Calciferol), paricalcitol (Zemplar) or any other medications or vitamins. ... consumerreports.org The Top 50: Harrison and Star Business Group - Jul 1, 2007 Abbott Labs, for which H&S already handled Humira and Kaletra, tapped the firm for the US and global Zemplar assignment and HIV therapy Aluvia. ... Medical Marketing & Media - Medical Marketing and Media Abbott Labs' Net Jumps 38% Amid Strong Product Sales - Jul 13, 2005 Abbott said about half the gain went to support the launch of oral drug Zemplar for kidney failure. The remainder added about a penny to earnings per share ... Subscription - Wall Street Journal Online - Dow Jones & Company Abbott stock options challenged Thinner support: Proposal would have ... - Apr 23, 2005 These include Xinlay for late-stage prostate cancer, Zemplar for chronic kidney disease, and two new uses for Humira, the rheumatoid arthritis drug. ... $2.95 - News Sun - NewsBank Press Release: Cytochroma and Mitsubishi Tanabe Form Partnership for ... - Jul 30, 2008 ...extensive experience in successfully developing and commercializing new vitamin D therapies for the CKD market, including Zemplar(R) and Hectorol(R), ... Pay-Per-View - PR Newswire Europe - HighBeam Research Sepracor.(MANUFACTURERS)(appointments in Sepracor Inc.)(Brief … - Apr 1, 2007 The FDA has approved Abbott Laboratories' Zemplar (paricalcitol injection) for use in children and adolescent hemodialysis patients, ages 5 to 19, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Wholesale prices for Rx up 7% in '07.(NEWS) | Article from Medical … - Apr 1, 2008 Meridia and Zemplar IV/oral, a drug for treating secondary hyperparathyroidism. Patent expiry spelled an end to the GSK Wellbutrin XL account. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Cell Therapeutics.(Update) | Article from Medical Marketing & Media |... - Mar 1, 2007 Medical Marketing & Media; July 1, 2004 ; 700+ words ... ... with a string of smaller accounts, including Abbott Labs' Zemplar International, Bayer's Avelox ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Local Focus.(Business) | Article from Daily Herald (Arlington... - May 28, 2005 Abbott Laboratories Friday said it received Food and Drug Administration approval for an oral version of its kidney disease treatment, Zemplar. ... Pay-Per-View - Daily Herald - HighBeam Research ABBOTT LABORATORIES - Mar 1, 2008 ...such as Zemplar®, Calcijex®, Simdax®, and Survanta®. Through a network of distributors, the. division distributes its products to government agencies, ... $3,450.00 - GLOBAL INDUSTRY ANALYSTS KEY PLAYERS - Alacra Store Press Release: Cytochroma and Mitsubishi Tanabe form partnership for ... - Jul 30, 2008 ...extensive experience in successfully developing and commercializing new vitamin D therapies for the CKD market, including Zemplar(R) and Hectorol(R), ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Approves New Therapy for Secondary … - May 27, 2005 The FDA just approved Zemplar capsules, an oral activated vitamin D therapy that reduces parathyroid hormone levels in patients with SHPT. ... Pay-Per-View - PR Newswire - HighBeam Research Takeda and Abbott Laboratories.(marketing)(Brief Article) | Article... - Sep 1, 2005 The FDA has approved Abbott Laboratories' Zemplar (paricalcitol injection) for use in children and adolescent hemodialysis patients, ages 5 to 19, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research The first US generic.(Update) | Article from Medical Marketing &... - Feb 1, 2007 Meridia and Zemplar IV/oral, a drug for treating secondary hyperparathyroidism. Patent expiry spelled an end to the GSK Wellbutrin XL account. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: Christian Brothers Investment Services, ICCR … - Mar 22, 2007 ...for: pain (Brufen); antibiotics (Abbotic); blood clots (Clivarine); arthritis (Humira); high-blood pressure (Tarka); and kidney disease (Zemplar). ... Pay-Per-View - PR Newswire - HighBeam Research Canadian drugmaker Biovail announced plans to shed its US-based … - Jan 1, 2007 Meridia and Zemplar IV/oral, a drug for treating secondary hyperparathyroidism. Patent expiry spelled an end to the GSK Wellbutrin XL account. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Top 200 drugs used in hospitals in 2006.(Table) - Apr 16, 2007 5 Water 58621430.93 13.03 148 Geodon 58591555.21 -9.14 149 Alkeran 58073821.39 37.54 150 Avelox I.V. 57954960.00 581.25 151 Zemplar 56678568.28 9.80 152 ... $4.95 - Drug Topics - ECNext Harrison & Star Business Group: employee initiative readies ranks for... - Jul 1, 2007 Abbott Labs, for which H&S already handled Humira and Kaletra, tapped the firm for the US and global Zemplar assignment and HIV therapy Aluvia. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: Cytochroma Announces Positive Comparative Data on … - Nov 6, 2008 ...paricalcitol (Zemplar(R)), the latter currently being the most widely used therapy for secondary hyperparathyroidism (SHPT) in the United States (U.S.). ... Pay-Per-View - PR Newswire - HighBeam Research Be careful with drugs - May 23, 2005 Other products that could earn FDA approval this year include Febuxostat for gout and an oral version of Zemplar for parathyroidism. ... $1.95 - Dow Theory Forecasts - Horizon Publishing Company |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |